Final answer:
Apart from FEV1, parameters that should be considered while evaluating the therapeutic potential of a compound for COPD include symptoms, exercise tolerance, and exacerbation rates.
Step-by-step explanation:
When evaluating the therapeutic potential of any compound used for the treatment of COPD, apart from FEV1 (forced expiratory volume in one second), other important parameters that should be considered are symptoms, exercise tolerance, and exacerbation rates. These parameters provide additional insight into the effectiveness of the compound beyond just measuring lung function. By assessing symptoms, exercise tolerance, and exacerbation rates, researchers can better understand the overall impact of the compound on the patient's quality of life and disease progression.